These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35391843)

  • 1. Twenty-Four Hour Blood Pressure Response to Empagliflozin and Its Determinants in Normotensive Non-diabetic Subjects.
    Zanchi A; Pruijm M; Muller ME; Ghajarzadeh-Wurzner A; Maillard M; Dufour N; Bonny O; Wuerzner G; Burnier M
    Front Cardiovasc Med; 2022; 9():854230. PubMed ID: 35391843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and Chronic Effects of SGLT2 Inhibitor Empagliflozin on Renal Oxygenation and Blood Pressure Control in Nondiabetic Normotensive Subjects: A Randomized, Placebo-Controlled Trial.
    Zanchi A; Burnier M; Muller ME; Ghajarzadeh-Wurzner A; Maillard M; Loncle N; Milani B; Dufour N; Bonny O; Pruijm M
    J Am Heart Assoc; 2020 Jul; 9(13):e016173. PubMed ID: 32567439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty-Four-Hour Blood Pressure-Lowering Effect of a Sodium-Glucose Cotransporter 2 Inhibitor in Patients With Diabetes and Uncontrolled Nocturnal Hypertension: Results From the Randomized, Placebo-Controlled SACRA Study.
    Kario K; Okada K; Kato M; Nishizawa M; Yoshida T; Asano T; Uchiyama K; Niijima Y; Katsuya T; Urata H; Osuga JI; Fujiwara T; Yamazaki S; Tomitani N; Kanegae H
    Circulation; 2019 Apr; 139(18):2089-2097. PubMed ID: 30586745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of NWT-03, an egg-protein hydrolysate, on blood pressure in normotensive, high-normotensive and mild-hypertensive men and women: a dose-finding study.
    Plat J; Severins N; Morrison S; Mensink RP
    Br J Nutr; 2017 Apr; 117(7):942-950. PubMed ID: 28485264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early alterations of blood pressure in normotensive and normoalbuminuric Type 1 diabetic patients.
    Cohen CN; Filho FM; de Fátima Gonçalves M; Gomes MB
    Diabetes Res Clin Pract; 2001 Aug; 53(2):85-90. PubMed ID: 11403856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetes.
    Kawasoe S; Maruguchi Y; Kajiya S; Uenomachi H; Miyata M; Kawasoe M; Kubozono T; Ohishi M
    BMC Pharmacol Toxicol; 2017 Apr; 18(1):23. PubMed ID: 28391776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of SGLT2i on 24-hour ambulatory blood pressure in patients with type 2 diabetes complicating hypertension: a meta-analysis].
    Tian L; Wang QY; Sun RM; Qi MM; Li YX; Gao X; Zhang LQ; Ma X; Shi H; Yu J; Bai F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Oct; 49(10):1000-1011. PubMed ID: 34674438
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study.
    Gunawardhana L; McLean L; Punzi HA; Hunt B; Palmer RN; Whelton A; Feig DI
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29102979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial.
    Bosch A; Ott C; Jung S; Striepe K; Karg MV; Kannenkeril D; Dienemann T; Schmieder RE
    Cardiovasc Diabetol; 2019 Mar; 18(1):44. PubMed ID: 30922297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quanduzhong capsules for the treatment of grade 1 hypertension patients with low-to-moderate risk: A multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Xu X; Tian W; Duan W; Pan C; Huang M; Wang Q; Yang Q; Wen Z; Tang Y; Xiong Y; Zhu Z; Liu Y; Wei D; Qi W; Ouyang X; Ying S; Wang X; Zhou Z; Li X; Cui Y; Yang S; Xu H
    Front Pharmacol; 2022; 13():1014410. PubMed ID: 36703729
    [No Abstract]   [Full Text] [Related]  

  • 12. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes.
    Ayala DE; Moyá A; Crespo JJ; Castiñeira C; Domínguez-Sardiña M; Gomara S; Sineiro E; Mojón A; Fontao MJ; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):99-115. PubMed ID: 23098178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihyperglycemic and Blood Pressure Effects of Empagliflozin in Black Patients With Type 2 Diabetes Mellitus and Hypertension.
    Ferdinand KC; Izzo JL; Lee J; Meng L; George J; Salsali A; Seman L
    Circulation; 2019 Apr; 139(18):2098-2109. PubMed ID: 30786754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Sodium-Glucose Cotransporter 2 Inhibitors on 24-Hour Ambulatory Blood Pressure: A Systematic Review and Meta-Analysis.
    Baker WL; Buckley LF; Kelly MS; Bucheit JD; Parod ED; Brown R; Carbone S; Abbate A; Dixon DL
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28522675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Empagliflozin on Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension by Background Antihypertensive Medication.
    Mancia G; Cannon CP; Tikkanen I; Zeller C; Ley L; Woerle HJ; Broedl UC; Johansen OE
    Hypertension; 2016 Dec; 68(6):1355-1364. PubMed ID: 27977392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of GH replacement on 24-h ambulatory blood pressure and its circadian rhythm in adult GH deficiency.
    Ahmad AM; Hopkins MT; Weston PJ; Fraser WD; Vora JP
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):431-7. PubMed ID: 11966735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone reduces office and diastolic ambulatory blood pressure following 1-year treatment in non-diabetic subjects with insulin resistance.
    Nilsson PM; Hedblad B; Donaldson J; Berglund G
    Blood Press; 2007; 16(2):95-100. PubMed ID: 17612907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effect of angiotensin II receptor blockade in postmenopausal women on a high-sodium diet: A double-blind, randomized, placebo-controlled study.
    Pechère-Bertschi A; Maillard M; Bischof P; Fathi M; Burnier M
    Curr Ther Res Clin Exp; 2008 Dec; 69(6):467-79. PubMed ID: 24692821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of empagliflozin on blood pressure in dipper and non-dipper patients with type 2 diabetes mellitus and hypertension.
    Chilton R; Tikkanen I; Hehnke U; Woerle HJ; Johansen OE
    Diabetes Obes Metab; 2017 Nov; 19(11):1620-1624. PubMed ID: 28387058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.